1 |
Proteomic analysis of the skeletal muscles from dysferlinopathy patients.J Clin Neurosci. 2020 Jan;71:186-190. doi: 10.1016/j.jocn.2019.08.068. Epub 2019 Aug 19.
|
2 |
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
|
3 |
ANO5-muscular dystrophy: clinical, pathological and molecular findings.Eur J Neurol. 2013 Oct;20(10):1383-9. doi: 10.1111/ene.12191. Epub 2013 May 12.
|
4 |
Common recessive limb girdle muscular dystrophies differential diagnosis: why and how?.Arq Neuropsiquiatr. 2014 Sep;72(9):721-34. doi: 10.1590/0004-282x20140110.
|
5 |
Gene co-expression network analysis of dysferlinopathy: Altered cellular processes and functional prediction of TOR1AIP1, a novel muscular dystrophy gene.Neuromuscul Disord. 2017 Mar;27(3):269-277. doi: 10.1016/j.nmd.2016.10.011. Epub 2016 Nov 3.
|
6 |
Muscle atrophy, ubiquitin-proteasome, and autophagic pathways in dysferlinopathy.Muscle Nerve. 2014 Sep;50(3):340-7. doi: 10.1002/mus.24167. Epub 2014 May 17.
|
|
|
|
|
|
|